Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYRN

Cyren (CYRN) Stock Price, News & Analysis

Cyren logo

About Cyren Stock (NASDAQ:CYRN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.21
$0.92
52-Week Range
N/A
Volume
1.15 million shs
Average Volume
1.43 million shs
Market Capitalization
$1.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyren and its competitors with MarketBeat's FREE daily newsletter.

CYRN Stock News Headlines

Peyto Exploration&Development Corp (PEY)
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Why Is Cyren (CYRN) Stock Down 27% Today?
Cyren Announces Nasdaq Delisting Determination
Cyren Announces Liquidation
Why Is Cyren (CYRN) Stock Up 43% Today?
See More Headlines

CYRN Stock Analysis - Frequently Asked Questions

Cyren Ltd. (NASDAQ:CYRN) posted its earnings results on Monday, November, 15th. The technology company reported ($0.06) EPS for the quarter, meeting the consensus estimate of ($0.06). The technology company had revenue of $7.46 million for the quarter. Cyren had a negative trailing twelve-month return on equity of 206.16% and a negative net margin of 123.96%.

Cyren subsidiaries include these companies: eleven GmbH, FRISK Software International, Authentium, Wingtra, Cyren Gesellschaft mbH, Cyren Iceland hf, Cyren Inc., and Cyren UK Ltd..

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyren investors own include Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Vaxart (VXRT), Acasti Pharma (ACST), iBio (IBIO), Oragenics (OGEN) and OpGen (OPGN).

Company Calendar

Last Earnings
11/15/2021
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRN
CIK
1084577
Employees
200
Year Founded
1991

Profitability

EPS (Trailing Twelve Months)
($5.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.04 million
Net Margins
-123.96%
Pretax Margin
-94.37%
Return on Equity
-206.16%
Return on Assets
-48.72%

Debt

Debt-to-Equity Ratio
2.30
Current Ratio
1.29
Quick Ratio
1.29

Sales & Book Value

Annual Sales
$31.19 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.05 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,780,000
Free Float
7,539,000
Market Cap
$1.70 million
Optionable
Not Optionable
Beta
0.83

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:CYRN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners